BIOMAT Database Logo BIOMAT Database Logo

In-hospital cardiac arrest characteristics, CPR quality, and outcomes in children with COVID-19. 2021

Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Research Center for Emergency Medicine, Aarhus University Hospital, Denmark; Emergency Department, Randers Regional Hospital, Denmark; Center for Pediatric Resuscitation, Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, USA. Electronic address: lauridsekg@email.chop.edu.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004632 Emergency Medical Services Services specifically designed, staffed, and equipped for the emergency care of patients. Emergency Care,Emergency Health Services,Emergicenters,Prehospital Emergency Care,Emergency Care, Prehospital,Emergency Services, Medical,Medical Services, Emergency,Services, Emergency Medical,Emergency Health Service,Emergency Medical Service,Emergency Service, Medical,Emergicenter,Health Service, Emergency,Health Services, Emergency,Medical Emergency Service,Medical Emergency Services,Medical Service, Emergency,Service, Emergency Health,Service, Emergency Medical,Service, Medical Emergency,Services, Emergency Health,Services, Medical Emergency
D006761 Hospitals Institutions with an organized medical staff which provide medical care to patients. Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D016887 Cardiopulmonary Resuscitation The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE. Basic Cardiac Life Support,CPR,Code Blue,Mouth-to-Mouth Resuscitation,Cardio-Pulmonary Resuscitation,Life Support, Basic Cardiac,Cardio Pulmonary Resuscitation,Mouth to Mouth Resuscitation,Mouth-to-Mouth Resuscitations,Resuscitation, Cardio-Pulmonary,Resuscitation, Cardiopulmonary,Resuscitation, Mouth-to-Mouth,Resuscitations, Mouth-to-Mouth
D058687 Out-of-Hospital Cardiac Arrest Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment. Out-of-Hospital Heart Arrest,Cardiac Arrest, Out-of-Hospital,Cardiac Arrests, Out-of-Hospital,Heart Arrest, Out-of-Hospital,Heart Arrests, Out-of-Hospital,Out of Hospital Cardiac Arrest,Out of Hospital Heart Arrest,Out-of-Hospital Cardiac Arrests,Out-of-Hospital Heart Arrests

Related Publications

Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19.
December 2020, Resuscitation plus,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
CPR quality and outcomes after extracorporeal life support for pediatric In-Hospital cardiac arrest.
August 2023, Resuscitation,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Cohort study of the characteristics and outcomes in patients with COVID-19 and in-hospital cardiac arrest.
November 2021, BMJ open,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19.
February 2021, JAMA internal medicine,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Impact of a COVID-19 code blue protocol on resuscitation care and CPR quality during in-hospital cardiac arrest.
May 2024, Resuscitation,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
CPR quality during out-of-hospital cardiac arrest transport.
May 2017, Resuscitation,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
Characteristics and outcomes of in-hospital cardiac arrest in COVID-19. A systematic review and meta-analysis.
January 2021, Cardiology journal,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
In-Hospital Cardiac Arrest (IHCA) and Outcomes in Patients Admitted With COVID-19 Infection.
June 2021, Cureus,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China.
June 2020, Resuscitation,
Kasper G Lauridsen, and Ryan W Morgan, and Maya Dewan, and Orsola Gawronski, and Anita I Sen, and
The association of race with CPR quality following out-of-hospital cardiac arrest.
January 2022, Resuscitation,
Copied contents to your clipboard!